Condition
Memory Loss
ClinicalTrials.gov condition label
Clinical trials
18 shownDevelopment of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD DementiaNCT06584357 · 2024-09-26
RECRUITINGA SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness ResponsesNCT05877196 · 2023-06-22
RECRUITINGNon-invasive Brain Stimulation for Cognitive and Motor Dysfunction in DementiaNCT05661084 · 2023-01-24
RECRUITINGUnderstanding Brain Mechanisms Involved in Autobiographical MemoryNCT05710549 · 2022-04-25
RECRUITINGGenetic Studies of Early-onset DementiaNCT04906863 · 2016-09-14
RECRUITINGPlans4Care: Personalized Dementia Care on DemandNCT07115251 · 2025-08-30
NOT_YET_RECRUITINGThe PorchLight ProjectNCT05550727 · 2022-09-23
ACTIVE_NOT_RECRUITINGIdentification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)NCT05364307 · 2022-06-13
COMPLETEDA Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)NCT04733989 · 2021-04-21
COMPLETEDHome-based Brain Stimulation for MemoryNCT04783350 · 2020-07-06
COMPLETEDExploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's DiseaseNCT07294586 · 2019-10-28
COMPLETEDCare to Plan: a Tailored Resource for Family Members of Persons With DementiaNCT03901456 · 2019-09-01
COMPLETEDStudy of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)NCT03661034 · 2018-05-31
UNKNOWNEPIC: An Intervention for Early-stage AD Dyads - Adapted for Virtual DeliveryNCT03144921 · 2017-12-12
COMPLETEDEffectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and BehaviorNCT03149380 · 2017-01-01
WITHDRAWNSafety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's DiseaseNCT01354691 · 2011-02-01
COMPLETEDScreening for Memory StudiesNCT01123018 · 2007-06-01
COMPLETEDEfficacy of Early Stage Alzheimer's Support GroupsNCT00391794 · 2006-09-01
COMPLETEDCommon interventions
Biomarker Data CollectionOTHER2Transcranial alternating current stimulation (tACS)DEVICE2Blood drawGENETIC1Care to PlanBEHAVIORAL1Chair-based StretchBEHAVIORAL1Combined Aerobic Resistance Exercise (CARE)BEHAVIORAL1Early Stage Memory Loss Support GroupBEHAVIORAL1Educational SeminarBEHAVIORAL1GammaSense Stimulation System (non-invasive, non-significant risk)DEVICE1high-density electroencephalography (hdEEG)DEVICE1High-Intensity Interval Training (HIIT)BEHAVIORAL1ladostigil hemitartrateDRUG1Medical questionnaireOTHER1Memtrax Memory screening testBEHAVIORAL1MK6240RADIATION1Moderate Intensity Continuous Training (MICT)BEHAVIORAL1Neurocognitive testingOTHER1Plans4CareBEHAVIORAL1PorchLightOTHER1Prescreener databaseOTHER1psychoeducational skills training interventionBEHAVIORAL1Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (active)DEVICE1Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (sham)DEVICE1Transcranial alternating current stimulation (tACS) (sham); Transcranial direct current stimulation (tDCS) (active)DEVICE1Transcranial alternating current stimulation (tACS) (sham); Transcranial direct current stimulation (tDCS) (sham)DEVICE1
Leading sponsors
Arizona State University2GAP Innovations, PBC2Hebrew SeniorLife2University of Minnesota2Amoneta Diagnostics SAS1Avraham Pharmaceuticals Ltd1Cognito Therapeutics, Inc.1Columbia University1Global Alzheimer's Platform Foundation1John Wesson Ashford Jr1Lucie Bréchet1Plans4Care Inc1University of Washington1Weill Medical College of Cornell University1
Trial status mix
COMPLETED9
RECRUITING5
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
UNKNOWN1
WITHDRAWN1
Phase mix
NA10
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.